ctrl K

RayzeBio Inc. Common Stoc... (RYZB)

NASDAQ: RYZB · Real-Time Price · USD

62.49

0.01 (0.02%)

At close: Feb 23, 2024, 9:00 PM

RayzeBio Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	129.16M	50.57M	143.73M
Short-Term Investments	167.09M	148.6M	3.14M
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	347K	385K	135K
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	3.79M	3.26M	211K
Total Current Assets	300.04M	202.43M	147.08M
Property-Plant & Equipment	24.39M	13.57M	1.23M
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	24.74M	13.96M	1.37M
Total Assets	324.78M	216.38M	148.45M
Account Payables	2.62M	1.13M	176K
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	1.14M	1.85M	763K
Other Current Liabilities	6.69M	3.16M	564K
Total Current Liabilities	10.46M	6.13M	1.5M
Long-Term Debt	9.43M	7.21M	n/a
Other Long-Term Liabilities	416.19M	257.62M	149.78M
Total Long-Term Liabilities	425.61M	264.82M	149.78M
Total Liabilities	436.07M	270.96M	151.28M
Total Debt	10.57M	9.06M	763K
Common Stock	2K	2K	1K
Retained Earnings	-130.12M	-55.11M	-6.92M
Comprehensive Income	-553K	-239K	-1K
Shareholders Equity	-111.29M	-54.57M	-2.83M
Total Investments	167.09M	148.6M	3.14M